Journal
Annals of Hematology
Annals of Hematology journal covers all the fields of hematology, from benign to oncological diseases, including clinical, biological, and experimental topics ranging from diagnosis to...
Myelodysplastic syndromes (MDS) are hematological malignancies characterized by ineffective hematopoiesis and abnormal proliferation of blood cells. These disorders can lead to complications such as anemia, thrombocytopenia, and an increased risk of progression to acute myeloid leukemia. This collection is dedicated to studies enhancing our understanding of MDS, such as, research into the pathophysiology, genetic underpinnings, early detection, clinical manifestations, therapeutic strategies, and supportive care of these hematological malignancies.
This collection supports United Nations Sustainable Development Goals 3: Good Health & Well-Being. The peer review process for these articles is the same as the peer review process of the journal in general. Additionally, if the guest editors author an article in the special issue, they will not handle the peer review process.
Submit your manuscript to this collection through the participating journal.
-
Prof. Dr. Wolf-K. Hofmann
Wolf-K. Hofmann is professor of medicine and director of the Department of Hematology and Oncology as well as the chair of the Mannheim Cancer Center at University Hospital Mannheim, Germany. Since 2019, Professor Hofmann has been served as one of the two speakers of the German MDS-Study Group. He has been the principal investigator for numerous national and international clinical trials as well as basic research and translational research projects in MDS.
Showing 1-3 of 3 articles